Activity of oral atovaquone alone and in combination with antimony in experimental visceral leishmaniasis.
AUTOR(ES)
Murray, H W
RESUMO
BALB/c mice with established visceral infection caused by the intracellular protozoan Leishmania donovani were treated with oral atovaquone for 7 days. Treatment with 100 mg/kg of body weight per day was optimal and halted parasite replication in the liver. In mice treated with atovaquone, the effect of a suboptimal dose of pentavalent antimony was converted from partially leishmanistatic to leishmanicidal. These results demonstrate the in vivo antileishmanial effect of atovaquone and suggest a potential role for this oral agent in visceral leishmaniasis as an adjunct to conventional antimony treatment.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=163162Documentos Relacionados
- Activity of amphotericin B cholesterol dispersion (Amphocil) in experimental visceral leishmaniasis.
- Effector role of blood monocytes in experimental visceral leishmaniasis.
- Combination Therapy with Indolylquinoline Derivative and Sodium Antimony Gluconate Cures Established Visceral Leishmaniasis in Hamsters
- Visceral leishmaniasis.
- Effect of granulocyte-macrophage colony-stimulating factor in experimental visceral leishmaniasis.
